Estrella Immunopharma Faces Delisting Concerns
Ticker: ESLAW · Form: 8-K · Filed: May 2, 2025 · CIK: 1844417
| Field | Detail |
|---|---|
| Company | Estrella Immunopharma, INC. (ESLAW) |
| Form Type | 8-K |
| Filed Date | May 2, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, corporate-action
TL;DR
Estrella Immunopharma might get delisted, trading halted soon.
AI Summary
Estrella Immunopharma, Inc. filed an 8-K on May 2, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of April 30, 2025. The company was formerly known as TradeUP Acquisition Corp. and changed its name on February 4, 2021.
Why It Matters
This filing indicates potential issues with Estrella Immunopharma's continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- Estrella Immunopharma, Inc. (company) — Registrant
- TradeUP Acquisition Corp. (company) — Former company name
- April 30, 2025 (date) — Date of earliest event reported
- May 2, 2025 (date) — Filing date
- February 4, 2021 (date) — Date of name change
FAQ
What specific listing rule or standard has Estrella Immunopharma failed to satisfy?
The filing does not specify the exact rule or standard that Estrella Immunopharma has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the exact date of the event triggering this 8-K filing?
The date of the earliest event reported is April 30, 2025.
When did Estrella Immunopharma change its name from TradeUP Acquisition Corp.?
The company changed its name from TradeUP Acquisition Corp. on February 4, 2021.
What is Estrella Immunopharma's primary business according to the filing?
Estrella Immunopharma, Inc. is classified under BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].
What is the SEC file number for Estrella Immunopharma?
The SEC file number for Estrella Immunopharma, Inc. is 001-40608.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 2, 2025 regarding Estrella Immunopharma, Inc. (ESLAW).